C.Garcia-LarsenV.NataleP.et al
It also targets other cells in the pancreas to stop the glucagon signal for generating glucose in the liver.[ref] In clinical trials, GLP-1 RAs improved lipid profiles, increased satiety, slowed gastric emptying, reduced inflammation, and had neuroprotective effects.[ref] The slowing of gastric emptying and reducing inflammation may play a role in weight loss, along with the decrease in appetite and eating less
The specifics will really depend on your insurance coverage, the type of drug youre using, and your dosage
September 23 Product : UCBs Bimzelx Indication : Psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis UCBs Bimzelx was approved Monday for not one, but three chronic immune-mediated inflammatory diseases: psoriatic arthritis (PsA), non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS)